Concepedia
Statistics
Publications
9
Citations
250
H-Index
Active since
2013
Affiliations
University of Massachusetts Boston(Current)
Dana-Farber Cancer Institute
Harvard University
United States Department of Agriculture
University of Cincinnati
Hailemichael O. Yosief is an author at University of Massachusetts Boston specializing in pharmacology, pharmacy, and drug discovery.
Publications per year
2013–2022
Structure-Guided Design and Development of Potent and Selective Dual Bromodomain 4 (BRD4)/Polo-like Kinase 1 (PLK1) Inhibitors
Shuai Liu, Hailemichael O. Yosief, Lingling Dai et al. · Journal of Medicinal Chemistry · 2018 · 57 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +16
A Novel Bromodomain Inhibitor Reverses HIV-1 Latency through Specific Binding with BRD4 to Promote Tat and P-TEFb Association
Huachao Huang, Shuai Liu, Maxime Jean et al. · Frontiers in Microbiology · 2017 · 54 citations · Full text
Pharmacy, Pharmacology, Pharmacotherapy +17
Inhibition of Polo-like kinase 1 (PLK1) facilitates the elimination of HIV-1 viral reservoirs in CD4 <sup>+</sup> T cells ex vivo
Dawei Zhou, Tsuyoshi Hayashi, Maxime Jean et al. · Science Advances · 2020 · 32 citations · Full text
Life Sciences, Infectious Diseases, Molecular Biology +17
Development of Dimethylisoxazole-Attached Imidazo[1,2-<i>a</i>]pyridines as Potent and Selective CBP/P300 Inhibitors
Alex Muthengi, Virangika K. Wimalasena, Hailemichael O. Yosief et al. · Journal of Medicinal Chemistry · 2021 · 30 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +11
Small-Molecule Dual PLK1 and BRD4 Inhibitors are Active Against Preclinical Models of Pediatric Solid Tumors
Natalie Timme, Youjia Han, Shuai Liu et al. · Translational Oncology · 2019 · 28 citations · Full text
Medicine, Oncology, Pharmacology +15
1–5 of 9